Sino Biopharmaceutical Li... (SBHMY)
PNK: SBHMY
· Real-Time Price · USD
9.48
0.00 (0.00%)
At close: Apr 21, 2025, 3:37 PM
0.00% (1D)
| Bid | 9.36 |
| Market Cap | 8.97B |
| Revenue (ttm) | 23.02B |
| Net Income (ttm) | 3.65B |
| EPS (ttm) | 0.29 |
| PE Ratio (ttm) | 32.69 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | 10.52 |
| Volume | 100 |
| Avg. Volume (20D) | 78 |
| Open | 10.30 |
| Previous Close | 9.48 |
| Day's Range | 9.48 - 10.30 |
| 52-Week Range | 6.69 - 10.30 |
| Beta | 0.75 |
About SBHMY
Sino Biopharmaceutical Limited, an investment holding company, operates as a research and development pharmaceutical conglomerate in the People's Republic of China. It operates through three segments: Modernised Chinese Medicines and Chemical Medicines, Investment, and Others. The company's products include oncology medicines comprising Qingkeshu tablets, Anxian capsules, Yinishu tablets, Genike capsules, Anyue capsules, and Leweixin injections; ...
Industry Biotechnology
Sector Healthcare
IPO Date Sep 5, 2017
Employees 24,379
Stock Exchange PNK
Ticker Symbol SBHMY
Website https://www.sinobiopharm.com